We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 2INV market cap is 71.28M. The company's latest EPS is EUR 3.8550 and P/E is 3.19.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 68.42M | 217k | 250k | 1.55M | 174k |
| Operating Income | 56.32M | -846k | -329k | 986k | -491k |
| Net Income | 55.03M | -1.89M | -21.04M | 1.58M | 22.16M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 85.57M | 87.4M | 61.97M | 64.18M | 84.18M |
| Total Liabilities | 1.06M | 4.79M | 397k | 1.02M | 1.2M |
| Total Equity | 84.5M | 82.61M | 61.58M | 63.16M | 82.98M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -7.83M | -33.02M | 15.86M | 8.67M | -25.42M |
| Investing | 63.8M | -10.66M | -12.86M | -5.57M | 20.92M |
| Financing | -8.88M | 4.24M | -4.31M | N/A | -2.34M |
| Market Cap | 71.28M |
| Price to Earnings Ratio | 3.19 |
| Price to Sales Ratio | 405.94 |
| Price to Cash Ratio | 26.32 |
| Price to Book Ratio | 0.85 |
| Dividend Yield | - |
| Shares Outstanding | 5.75M |
| Average Volume (1 week) | 931 |
| Average Volume (1 Month) | 636 |
| 52 Week Change | 45.03% |
| 52 Week High | 12.90 |
| 52 Week Low | 8.20 |
| Spread (Intraday) | 0.5 (3.97%) |
| Company Name | 2invest AG |
| Address |
ziegelhaeuser landstr. 3 heidelberg 69120 |
| Website | https://www.2invest-ag.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
